Single‐dose oral challenges to validate eliciting doses in children with cow’s milk allergy

Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (...

Full description

Saved in:
Bibliographic Details
Published inPediatric allergy and immunology Vol. 32; no. 5; pp. 1056 - 1065
Main Authors Turner, Paul J., d'Art, Yvonne M., Duca, Bettina, Chastell, Sophia A., Marco‐Martin, Guadalupe, Vera‐Berrios, Rosialzira N., Alvarez, Olaya, Bazire, Raphaëlle, Rodríguez del Río, Pablo, Vazquez‐Ortiz, Marta, Baumert, Joseph L., van Ree, Ronald, Mills, Clare E. N., Fernandez‐Rivas, Montserrat, Hourihane, Jonathan O'B., Ebisawa, Motohiro
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.07.2021
Subjects
Online AccessGet full text
ISSN0905-6157
1399-3038
1399-3038
DOI10.1111/pai.13482

Cover

Abstract Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein. Methods Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity. Results 172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein. Conclusions These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.
AbstractList There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.BACKGROUNDThere is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.METHODSParticipants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein.RESULTS172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein.These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.CONCLUSIONSThese data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.
Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein. Methods Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity. Results 172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein. Conclusions These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.
There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED for cow's milk of 0.5 mg protein. Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity. 172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein. These data support an estimated ED for cow's milk of 0.5 mg protein. Values for ED above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.
BackgroundThere is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.MethodsParticipants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.Results172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein.ConclusionsThese data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.
Author Baumert, Joseph L.
Turner, Paul J.
Marco‐Martin, Guadalupe
Bazire, Raphaëlle
Mills, Clare E. N.
Ebisawa, Motohiro
Duca, Bettina
van Ree, Ronald
Fernandez‐Rivas, Montserrat
Vera‐Berrios, Rosialzira N.
Vazquez‐Ortiz, Marta
Hourihane, Jonathan O'B.
Alvarez, Olaya
Chastell, Sophia A.
Rodríguez del Río, Pablo
d'Art, Yvonne M.
Author_xml – sequence: 1
  givenname: Paul J.
  orcidid: 0000-0001-9862-5161
  surname: Turner
  fullname: Turner, Paul J.
  email: p.turner@imperial.ac.uk
  organization: Imperial College London
– sequence: 2
  givenname: Yvonne M.
  surname: d'Art
  fullname: d'Art, Yvonne M.
  organization: University College Cork
– sequence: 3
  givenname: Bettina
  surname: Duca
  fullname: Duca, Bettina
  organization: Imperial College London
– sequence: 4
  givenname: Sophia A.
  surname: Chastell
  fullname: Chastell, Sophia A.
  organization: Imperial College London
– sequence: 5
  givenname: Guadalupe
  surname: Marco‐Martin
  fullname: Marco‐Martin, Guadalupe
  organization: ARADyAL Research Network
– sequence: 6
  givenname: Rosialzira N.
  surname: Vera‐Berrios
  fullname: Vera‐Berrios, Rosialzira N.
  organization: ARADyAL Research Network
– sequence: 7
  givenname: Olaya
  surname: Alvarez
  fullname: Alvarez, Olaya
  organization: Health Research Institute Princesa
– sequence: 8
  givenname: Raphaëlle
  orcidid: 0000-0003-0079-3613
  surname: Bazire
  fullname: Bazire, Raphaëlle
  organization: Health Research Institute Princesa
– sequence: 9
  givenname: Pablo
  surname: Rodríguez del Río
  fullname: Rodríguez del Río, Pablo
  organization: Health Research Institute Princesa
– sequence: 10
  givenname: Marta
  orcidid: 0000-0001-5493-6056
  surname: Vazquez‐Ortiz
  fullname: Vazquez‐Ortiz, Marta
  organization: Imperial College London
– sequence: 11
  givenname: Joseph L.
  surname: Baumert
  fullname: Baumert, Joseph L.
  organization: University of Nebraska
– sequence: 12
  givenname: Ronald
  surname: van Ree
  fullname: van Ree, Ronald
  organization: Amsterdam University Medical Centres
– sequence: 13
  givenname: Clare E. N.
  surname: Mills
  fullname: Mills, Clare E. N.
  organization: University of Manchester
– sequence: 14
  givenname: Montserrat
  surname: Fernandez‐Rivas
  fullname: Fernandez‐Rivas, Montserrat
  organization: ARADyAL Research Network
– sequence: 15
  givenname: Jonathan O'B.
  orcidid: 0000-0003-4997-9857
  surname: Hourihane
  fullname: Hourihane, Jonathan O'B.
  organization: Children's Health Ireland
– sequence: 16
  givenname: Motohiro
  surname: Ebisawa
  fullname: Ebisawa, Motohiro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33608940$$D View this record in MEDLINE/PubMed
BookMark eNp90c1KxDAQB_Agiq4fB19AAl70UE2apk2OIn6BoKCeQ9pO12g2WZOuy958BK--nk9i1lUPguYSAr8ZJvNfR8vOO0Bom5IDms7hWJsDygqRL6EBZVJmjDCxjAZEEp6VlFdraD3GB0JoxUq6itYYK4mQBRkgdWPc0ML7y2vrI2AftMXNvbYW3BAi7j1-1ta0ugcM1jSmTxzPacTGJWlsG8DhqenvceOn7y9vEY-MfcTzFmE420QrnbYRtr7uDXR3enJ7fJ5dXp1dHB9dZg0TIs94I_KiFDXoSrCSiapkROeC8062rK5FmZei43mXfpueUra1gKprq6KFgsqGsA20t-g7Dv5pArFXIxMbsFY78JOo8kJSWXApi0R3f9EHPwkuTadynoYgrOI8qZ0vNalH0KpxMCMdZup7dQnsL0ATfIwBuh9CiZrHolIs6jOWZA9_2bRJ3Rvv-qCN_a9iaizM_m6tro8uFhUfPhOehg
CitedBy_id crossref_primary_10_1016_j_jaip_2021_05_021
crossref_primary_10_1111_all_16012
crossref_primary_10_1016_j_fct_2022_113381
crossref_primary_10_1016_j_jaip_2021_08_008
crossref_primary_10_1111_all_15397
crossref_primary_10_46563_1560_9561_2023_26_5_368_375
crossref_primary_10_1111_all_15863
crossref_primary_10_1111_all_15202
crossref_primary_10_1111_pai_13926
crossref_primary_10_1097_ACI_0000000000000906
crossref_primary_10_1097_ACI_0000000000000979
crossref_primary_10_1111_all_15749
crossref_primary_10_1016_j_jaip_2022_12_042
crossref_primary_10_1016_j_waojou_2024_100972
crossref_primary_10_1007_s11882_024_01129_x
crossref_primary_10_1016_j_jaci_2022_04_035
crossref_primary_10_1016_j_jaip_2022_10_044
crossref_primary_10_1016_j_waojou_2024_101012
crossref_primary_10_3390_nu15061397
crossref_primary_10_1016_j_anai_2023_12_012
crossref_primary_10_1159_000541840
crossref_primary_10_1016_j_jaci_2024_03_019
crossref_primary_10_1111_1541_4337_70132
Cites_doi 10.1016/j.jaci.2017.01.030
10.1111/j.1398-9995.2012.02865.x
10.1046/j.1365-2222.2000.00928.x
10.1016/j.alit.2017.02.001
10.1111/j.1399-3038.2010.00990.x
10.1111/all.12614
10.1016/j.jaci.2005.12.1303
10.1111/all.13198
10.1016/j.jaci.2013.06.042
10.1111/pai.12148
10.1111/all.12613
10.1016/j.jaip.2020.06.059
10.1186/s12889-018-6117-y
10.1016/j.jaci.2014.03.035
10.1016/j.jaci.2012.10.017
10.3389/fimmu.2018.02057
10.1016/j.fct.2013.10.032
10.1016/j.fct.2020.111831
10.1111/j.1398-9995.2011.02715.x
10.1016/j.fct.2020.111259
10.1067/mai.2001.114708
10.1016/j.jaci.2019.07.046
10.1016/j.jaip.2019.04.025
10.1186/s40413-016-0104-5
10.1136/bmj.d6180
10.1111/pai.13244
10.1111/all.12625
ContentType Journal Article
Copyright 2021 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
– notice: 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
– notice: 2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
NAPCQ
7X8
DOI 10.1111/pai.13482
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3038
EndPage 1065
ExternalDocumentID 33608940
10_1111_pai_13482
PAI13482
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Jon Moulton Charity Trust
– fundername: Medical Research Council
– fundername: Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica
– fundername: Fundación de la Sociedad Española de Alergología e Inmunología Clínica
– fundername: FP7 Food, Agriculture and Fisheries, Biotechnology
– fundername: NIHR Imperial Biomedical Research Centre
– fundername: ARADyAL
– fundername: Medical Research Council
  grantid: MR/S036954/1
– fundername: Department of Health
– fundername: Medical Research Council
  grantid: MR/K010468/1
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29O
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J8S
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
ESTFP
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c3882-5c82468bea7836387630a2855f9d3bb86268f52f1113bb99db8e7fd74de419c03
IEDL.DBID DR2
ISSN 0905-6157
1399-3038
IngestDate Fri Sep 05 12:02:25 EDT 2025
Sun Sep 07 00:40:35 EDT 2025
Mon Jul 21 05:35:44 EDT 2025
Tue Jul 01 01:25:26 EDT 2025
Thu Apr 24 22:57:35 EDT 2025
Wed Jan 22 16:28:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords cow's milk
eliciting dose
thresholds
Voluntary Incidental Trace Allergen Labelling (VITAL)
single-dose challenge
Language English
License Attribution
2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3882-5c82468bea7836387630a2855f9d3bb86268f52f1113bb99db8e7fd74de419c03
Notes Funding information
Clinical challenges in the SOCMA study were funded through grant funds awarded by Jon Moulton Charity Trust, UK Medical Research Council (ref MR/S036954/1), Sociedad Española de Alergología e Inmunología Clínica (SEAIC), Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica (SEICAP) and Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0026). iFAAM (Integrated Approaches to Food Allergen and Allergy Risk Management) challenges were funded through the European Union's Seventh Framework Program for research, technological development and demonstration (grant agreement no. 312147). Additional funding for the Irish centre was obtained via a research fellowship (YD) from the National Children's Research Centre of Ireland, and for Hospital Clinico San Carlos in Madrid by Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0009). PJT is supported through the NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR, or the Department of Health. The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0079-3613
0000-0003-4997-9857
0000-0001-9862-5161
0000-0001-5493-6056
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.13482
PMID 33608940
PQID 2546803755
PQPubID 105695
PageCount 10
ParticipantIDs proquest_miscellaneous_2491945994
proquest_journals_2546803755
pubmed_primary_33608940
crossref_primary_10_1111_pai_13482
crossref_citationtrail_10_1111_pai_13482
wiley_primary_10_1111_pai_13482_PAI13482
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2021
2021-07-00
20210701
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: July 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Montpellier
PublicationTitle Pediatric allergy and immunology
PublicationTitleAlternate Pediatr Allergy Immunol
PublicationYear 2021
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2019; 7
2015; 70
2013; 24
2017; 66
2020; 146
2014; 63
2012; 14
2014; 133
2001; 107
2018; 21
2006; 117
2019; 144
2017; 139
2014; 134
2016; 11
2020; 8
2017; 72
2012; 130
2018; 18
2020; 31
2020
2000; 30
2020; 139
2011; 22
2012; 67
2011; 343
e_1_2_12_4_1
e_1_2_12_3_1
e_1_2_12_6_1
e_1_2_12_5_1
e_1_2_12_19_1
e_1_2_12_18_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_16_1
Baseggio Conrado A (e_1_2_12_12_1) 2020
e_1_2_12_20_1
e_1_2_12_21_1
e_1_2_12_22_1
e_1_2_12_23_1
e_1_2_12_24_1
e_1_2_12_25_1
e_1_2_12_26_1
e_1_2_12_27_1
e_1_2_12_28_1
e_1_2_12_29_1
e_1_2_12_30_1
e_1_2_12_31_1
Levy MB (e_1_2_12_15_1) 2012; 14
e_1_2_12_14_1
e_1_2_12_13_1
e_1_2_12_8_1
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_10_1
e_1_2_12_9_1
References_xml – volume: 8
  start-page: 3660
  issue: 10
  year: 2020
  end-page: 3662
  article-title: Effect of specific IgE on eliciting dose in children with cow's milk allergy
  publication-title: J Allergy Clin Immunol Pract
– volume: 66
  start-page: 248
  issue: 2
  year: 2017
  end-page: 264
  article-title: Committee for Japanese pediatric guideline for food allergy, the Japanese Society of Pediatric Allergy and Clinical Immunology, The Japanese Society of Allergology. Japanese guidelines for food allergy 2017
  publication-title: Allergol Int
– volume: 67
  start-page: 107
  issue: 1
  year: 2012
  end-page: 113
  article-title: Development of a standardized low‐dose double‐blind placebo‐controlled challenge vehicle for the EuroPrevall project
  publication-title: Allergy
– volume: 70
  start-page: 1039
  issue: 9
  year: 2015
  end-page: 1051
  article-title: Precautionary allergen labelling: perspectives from key stakeholder groups
  publication-title: Allergy
– volume: 7
  start-page: 2241
  issue: 7
  year: 2019
  end-page: 2249
  article-title: Epidemiology of anaphylaxis in critically Ill children in the United States and Canada
  publication-title: J Allergy Clin Immunol Pract
– volume: 139
  year: 2020
  article-title: Updated population minimal eliciting dose distributions for use in risk assessment of 14 priority food allergens
  publication-title: Food Chem Toxicol
– volume: 30
  start-page: 1540
  issue: 11
  year: 2000
  end-page: 1546
  article-title: Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children
  publication-title: Clin Exp Allergy
– volume: 18
  start-page: 1263
  issue: 1
  year: 2018
  article-title: Comparing the eating out experiences of consumers seeking to avoid different food allergens
  publication-title: BMC Public Health
– volume: 70
  start-page: 880
  issue: 7
  year: 2015
  end-page: 883
  article-title: Increased incidence of admissions for anaphylaxis in Spain 1998–2011
  publication-title: Allergy
– volume: 24
  start-page: 624
  issue: 7
  year: 2013
  end-page: 626
  article-title: Persistent allergy to cow's milk: of greater a clinical concern than other food allergies
  publication-title: Pediatr Allergy Immunol
– volume: 146
  year: 2020
  article-title: Full range of population eliciting dose values for 14 priority allergenic foods and recommendations for use in risk characterization
  publication-title: Food Chem Toxicol
– volume: 31
  start-page: 601
  issue: 6
  year: 2020
  end-page: 607
  article-title: Can my child with IgE‐mediated peanut allergy introduce foods labeled with "may contain traces"?
  publication-title: Pediatr Allergy Immunol
– volume: 70
  start-page: 813
  issue: 7
  year: 2015
  end-page: 819
  article-title: Unintended allergens in precautionary labelled and unlabelled products pose significant risks to UK allergic consumers
  publication-title: Allergy
– volume: 133
  start-page: 156
  issue: 1
  year: 2014
  end-page: 164
  article-title: Allergen reference doses for precautionary labeling (VITAL 2.0): clinical implications
  publication-title: J Allergy Clin Immunol
– volume: 134
  start-page: 390
  issue: 2
  year: 2014
  end-page: 398
  article-title: Modified oral food challenge used with sensitisation biomarkers provides more real‐life clinical thresholds for peanut allergy
  publication-title: J Allergy Clin Immunol
– volume: 21
  start-page: 2057
  issue: 9
  year: 2018
  article-title: Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges
  publication-title: Front Immunol
– volume: 107
  start-page: 891
  issue: 5
  year: 2001
  end-page: 896
  article-title: Utility of food‐specific IgE concentrations in predicting symptomatic food allergy
  publication-title: J Allergy Clin Immunol
– volume: 63
  start-page: 9
  year: 2014
  end-page: 17
  article-title: Establishment of reference doses for residues of allergenic foods: report of the VITAL Expert Panel
  publication-title: Food Chem Toxicol
– volume: 130
  start-page: 1260
  issue: 6
  year: 2012
  end-page: 1274
  article-title: Standardizing double‐blind, placebo‐controlled oral food challenges: American Academy of Allergy, Asthma & Immunology‐European Academy of Allergy and Clinical Immunology PRACTALL consensus report
  publication-title: J Allergy Clin Immunol
– volume: 343
  start-page: d6180
  year: 2011
  article-title: Advisory food labels: consumers with allergies need more than "traces" of information
  publication-title: BMJ
– volume: 144
  start-page: 1290
  issue: 5
  year: 2019
  end-page: 1309
  article-title: Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens
  publication-title: J Allergy Clin Immunol
– volume: 139
  start-page: 1583
  issue: 5
  year: 2017
  end-page: 1590
  article-title: Peanut Allergen Threshold Study (PATS): novel single‐dose oral food challenge study to validate eliciting doses in children with peanut allergy
  publication-title: J Allergy Clin Immunol
– volume: 22
  start-page: 172
  issue: 2
  year: 2011
  end-page: 177
  article-title: Anaphylaxis in Israel: experience with 92 hospitalized children
  publication-title: Pediatr Allergy Immunol
– volume: 72
  start-page: 1816
  issue: 11
  year: 2017
  end-page: 1819
  article-title: Minimal impact of extensive heating of hen's egg and cow's milk in a food matrix on threshold dose‐distribution curves
  publication-title: Allergy
– volume: 14
  start-page: 29
  issue: 1
  year: 2012
  end-page: 33
  article-title: Lessons from 482 cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen
  publication-title: Isr Med Assoc J
– year: 2020
  article-title: Food Anaphylaxis in the United Kingdom: an analysis of national data. 1998–2018
  publication-title: BMJ
– volume: 67
  start-page: 976
  year: 2012
  end-page: 997
  article-title: International consensus on (ICON) pediatric asthma
  publication-title: Allergy
– volume: 11
  start-page: 12
  issue: 9
  year: 2016
  article-title: Allergic reactions to milk appear sooner than reactions to hen's eggs: a retrospective study
  publication-title: World Allergy Organ J
– volume: 117
  start-page: 391
  year: 2006
  end-page: 397
  article-title: Second symposium on the definition and management of anaphylaxis: summary report—second national institute of allergy and infectious disease/food allergy and anaphylaxis network symposium
  publication-title: J Allergy Clin Immunol
– ident: e_1_2_12_4_1
  doi: 10.1016/j.jaci.2017.01.030
– ident: e_1_2_12_19_1
  doi: 10.1111/j.1398-9995.2012.02865.x
– ident: e_1_2_12_30_1
  doi: 10.1046/j.1365-2222.2000.00928.x
– ident: e_1_2_12_26_1
  doi: 10.1016/j.alit.2017.02.001
– ident: e_1_2_12_27_1
– ident: e_1_2_12_13_1
  doi: 10.1111/j.1399-3038.2010.00990.x
– ident: e_1_2_12_22_1
  doi: 10.1111/all.12614
– ident: e_1_2_12_21_1
  doi: 10.1016/j.jaci.2005.12.1303
– ident: e_1_2_12_28_1
  doi: 10.1111/all.13198
– ident: e_1_2_12_8_1
  doi: 10.1016/j.jaci.2013.06.042
– year: 2020
  ident: e_1_2_12_12_1
  article-title: Food Anaphylaxis in the United Kingdom: an analysis of national data. 1998–2018
  publication-title: BMJ
– ident: e_1_2_12_10_1
  doi: 10.1111/pai.12148
– ident: e_1_2_12_11_1
  doi: 10.1111/all.12613
– ident: e_1_2_12_18_1
  doi: 10.1016/j.jaip.2020.06.059
– ident: e_1_2_12_16_1
  doi: 10.1186/s12889-018-6117-y
– ident: e_1_2_12_9_1
  doi: 10.1016/j.jaci.2014.03.035
– ident: e_1_2_12_7_1
  doi: 10.1016/j.jaci.2012.10.017
– ident: e_1_2_12_17_1
  doi: 10.3389/fimmu.2018.02057
– ident: e_1_2_12_2_1
  doi: 10.1016/j.fct.2013.10.032
– volume: 14
  start-page: 29
  issue: 1
  year: 2012
  ident: e_1_2_12_15_1
  article-title: Lessons from 482 cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen
  publication-title: Isr Med Assoc J
– ident: e_1_2_12_23_1
  doi: 10.1016/j.fct.2020.111831
– ident: e_1_2_12_20_1
  doi: 10.1111/j.1398-9995.2011.02715.x
– ident: e_1_2_12_3_1
  doi: 10.1016/j.fct.2020.111259
– ident: e_1_2_12_31_1
  doi: 10.1067/mai.2001.114708
– ident: e_1_2_12_6_1
  doi: 10.1016/j.jaci.2019.07.046
– ident: e_1_2_12_14_1
  doi: 10.1016/j.jaip.2019.04.025
– ident: e_1_2_12_29_1
  doi: 10.1186/s40413-016-0104-5
– ident: e_1_2_12_24_1
  doi: 10.1136/bmj.d6180
– ident: e_1_2_12_5_1
  doi: 10.1111/pai.13244
– ident: e_1_2_12_25_1
  doi: 10.1111/all.12625
SSID ssj0017361
Score 2.4388454
Snippet Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution...
There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold...
BackgroundThere is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1056
SubjectTerms Allergens
Allergies
Anaphylaxis
Animals
Cattle
Cheese
Child
Children
Cow's milk
eliciting dose
Epinephrine
Female
Food allergies
Humans
Male
Milk
Milk Hypersensitivity - diagnosis
Proteins
single‐dose challenge
thresholds
Voluntary Incidental Trace Allergen Labelling (VITAL)
Title Single‐dose oral challenges to validate eliciting doses in children with cow’s milk allergy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.13482
https://www.ncbi.nlm.nih.gov/pubmed/33608940
https://www.proquest.com/docview/2546803755
https://www.proquest.com/docview/2491945994
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwEB6VHhAXoKwP2sogDlzy5MR2YotT1VIVpKIKqNQDUuQtKOojqZr3hODUn8CVv9dfgsdZRFkkxC1SJvE2Y8-MZ74BeOYFZV5yk2jEGeKSukSnqU2EdimVlTI85lYdvskPjvnrE3GyBi_GXJgeH2JyuKFkxP0aBVyb7ichP9P1PEVolrD_pixH3Py9txN0VFqwiJVKFRXBPBLFgCqEUTzTl1fPot8UzKv6ajxw9m_Bh7GrfZzJ6Xy1NHP79RcUx_8cy224OSiiZKfnnA1Y880duH44XLXfhfJdONQW_vLim2s7TzCRn9ix8kpHli0JPFqjv4CExm2N4dMESTtSN2TMESfo5yW2_Xx58b0jn-rFKcFfnH_8cg-O91--3z1IhmoMiWWohgsrM55L4zUmfjBEsqM6k0JUyjFj0DKSlcgqrF1vjFLOSF9UruDO81RZyu7DetM2_iEQvHo1ufYmD8alzAtji4K6wtlcp0ZZNoPn47qUdoAqx4oZi3I0WcKElXHCZvB0Ij3r8Tn-RLQ5Lm45iGhXYiEAiRWAxQyeTK-DcOGNiW58uwo0XKWKC6X4DB70TDG1wlhOpeI0dDYu7d-bL492XsWHR_9O-hhuZBg9EwODN2F9eb7yW0H9WZptuJbxo-3I7T8A-08Bnw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkEvvGkXChjEgUtWztpObKmXClFtoVshaKVeUBQ_gqJuk6rZFYJTfwLX_r3-EjzOQ5SHhLhFyiR27Jl4nt8AvHSCMie5jnLEGeKS2iiPYxOJ3MZUFkrzUFs120-mh_ztkThaga2-FqbFhxgcbigZ4X-NAo4O6Z-k_DQvxzFis1yD6yE-hyrRhwE8Kk5ZQEuligpvIIm0wxXCPJ7h0aun0W8q5lWNNRw5O7fhUz_ZNtPkeLxc6LH59guO4_9-zR241emiZLtlnruw4qp7cGPWRdvvQ_bRn2tzd3n-3daNI1jLT0zffKUhi5p4Ni3RZUD86KbEDGqCpA0pK9KXiRN09RJTf7k8v2jISTk_JviKs89fH8DhzpuD19Ooa8gQGYaauDBywhOpXY61HwzB7Gg-kUIUyjKt0TiShZgU2L5ea6Wsli4tbMqt47EylD2E1aqu3AYQjL7qJHc68falTFJt0pTa1Jokj7UybASv-o3JTIdWjk0z5llvtfgFy8KCjeDFQHraQnT8iWiz392sk9Imw14AEpsAixE8H257-cKgSV65eulpuIoVF0rxEay3XDGMwlhCpeLUTzbs7d-Hz95v74aLR_9O-gxuTg9me9ne7v67x7A2wWSakCe8CauLs6V74rWhhX4amP4H_SQE5g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwEB61Rap6QS0_ZWkBgzhwCXJiO7HFqaKsWqDVSlCpt8h_QRFLsmq2Qtz6CFx5vT4JHm8SUUElbpEyiePxTDzjmfkG4KUXlHnJTaIRZ4hL6hKdpjYR2qVUVsrwWFt1cpofnfH35-J8Dd4MtTArfIjxwA01I_6vUcEXrvpDyRe6fp0iNMs63OFB7lC8Mz4bQwgFi2CpVFER_CNR9LBCmMYzPnpzM_rLwrxpsMYdZ7oNd3tTkRys1nYH1nxzDzZP-mD4fSg_hW1n7q-vfrq28wRL7YkdeqN0ZNmSIEU1evQkTNXWmOBMkLQjdUOGKm6CJ7HEtt-vr3515Fs9_0rwFRdffjyAs-m7z2-Pkr5fQmIZGsrCyozn0niNpRkMseaozqQQlXLMGPRdZCWyCrvLG6OUM9IXlSu48zxVlrKHsNG0jX8EBIOjJtfe5MH9k3lhbFFQVzib69QoyybwamBcaXswcexpMS8HpyLwuIw8nsCLkXSxQtD4F9H-wP2yV6KuRKh-iT16xQSej7eD-GNMQze-vQw0XKWKC6X4BHZXqzaOwlhOpeI0fGxcxtuHL2cHx_Hi8f-TPoPN2eG0_Hh8-mEPtjJMdYlZvPuwsby49E-CrbI0T6NM_gZujuNY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single%E2%80%90dose+oral+challenges+to+validate+eliciting+doses+in+children+with+cow%E2%80%99s+milk+allergy&rft.jtitle=Pediatric+allergy+and+immunology&rft.au=Turner%2C+Paul+J.&rft.au=d%27Art%2C+Yvonne+M.&rft.au=Duca%2C+Bettina&rft.au=Chastell%2C+Sophia+A.&rft.date=2021-07-01&rft.issn=0905-6157&rft.eissn=1399-3038&rft.volume=32&rft.issue=5&rft.spage=1056&rft.epage=1065&rft_id=info:doi/10.1111%2Fpai.13482&rft.externalDBID=10.1111%252Fpai.13482&rft.externalDocID=PAI13482
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-6157&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-6157&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-6157&client=summon